Prognostic significance of estrogen receptors in 405 primary breast cancers: A comparison of immunohistochemical and biochemical methods

Breast Cancer Research and Treatment

Volumn 45, Issue 3, 1997, Pages 241-249

  Molino, A ^a,e   Micciolo, R ^b   Turazza, M ^a   Bonetti, F ^a   Piubello, Q ^c   Corgnati, A ^a   Sperotto, L ^a   Recaldin, E ^d   Spagnolli, P ^d   Manfrin, E ^a   Bonetti, A ^a   Nortilli, R ^a   Tomezzoli, A ^c   Pollini, G P ^a   Modena, S ^a   Cetto, G L ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF TRENTO   (Italy)

^c Civic Hospital of Verona   (Italy)

^d 'S Cuore' Hospital   (Italy)

^e MAGGIORE HOSPITAL   (Italy)

Author keywords

Biochemistry; Breast cancer; Estrogen receptors; Immunohistochemistry; Prognosis

Indexed keywords

CHARCOAL; DEXTRAN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGE; AGED; ARTICLE; BIOCHEMISTRY; BREAST CANCER; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LYMPH NODE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TUMOR VOLUME;

ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; CHARCOAL; DEXTRANS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTORS, ESTROGEN;

EID: 9844235923     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005769925670     Document Type: Article

References (41)

1. Wollenweider-Zerargui L, Barrelet L, Wong Y et al.: The predictive value of estrogen and progesterone receptor concentrations on the clinical behavior of breast cancer in women. Clinical correlations in 547 patients. Cancer 57: 1171- 1180, 1988
2. Williams MR, Todd JH, Ellis IO et al.: Oestrogen receptors in primary and advanced breast cancer. An eight-year review of 704 cases. Br J Cancer 55: 67-73, 1987
3. Alexieva-Figusch J, Van Putten WL, Blankestein M: The prognostic value and relationships of patient characteristics, estrogen and progestin receptors, and site of relapse in primary breast cancer. Cancer 61: 758-768, 1988
4. Clark GM, McGuire WL: Steroid receptors and other prognostic factors in primary breast cancer. Semin Oncol 15 (supp.): 20-25, 1988
5. Molino A, Turazza M, Bonetti A et al.: Estrogen and progesterone receptors in breast cancer: correlation with clinical and pathological features and with prognosis. Oncology 49: 82-88, 1992
6. Early Breast Cancer Trialists Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy. Lancet 339: 1-15, 71-85, 1992
7. Pertschuk LP, Eisenberg KB, Carter AC et al.: Immunohistologic localization of estrogen receptors in breast cancer with monoclonal antibodies. Cancer 55: 1513-1518, 1985
8. McCarty KS Jr, Miller LS, Cox EB et al.: Estrogen receptor analysis. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Path Lab Med 109: 716-721, 1985
9. Pascal RR, Santeusano G, Sarrel D et al.: Immunohistologic detection of estrogen receptors in paraffin-embedded breast cancers: correlation with cytosol measurements. Hum Path 17: 370-375, 1986
10. Reiner A, Reiner G, Spona J et al.: Estrogen receptor analysis on biopsies and fine-needle aspirates from human breast carcinoma: correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Am J Pathol 125: 443-449, 1986
11. Bruun Rasmussen B, Thorpe SM, Norgaard T et al.: Immunohistochemical steroid receptor detection in frozen breast cancer tissue. A multicenter investigation. Acta Oncologica 27(6A): 757-760, 1988
12. De Lena M, Marzullo F, Simone G et al.: Correlation between ER-IHC and DCC assay in hormone receptor assessment of human breast cancer. Oncology 45: 308-312, 1988
13. Helin HJ, Helle MJ, Helin ML et al.: Immunocytochemical detection of estrogen and progesterone receptors in 124 human breast cancers. Am J Pathol 89: 137-142, 1988
14. Scheres HME, De Goeij AFPM, Rousch MJM et al.: Quantification of oestrogen receptors in breast cancer: radiochemical assay on cytosols and cryostat sections compared with semiquantitative immunocytochemical analysis. J Clin Pathol 41: 623-632, 1988
15. Parl FF, Posey YF: Discrepancies of biochemical and immunohistochemical estrogen receptor assays in breast cancer. Human Pathology 19: 960-966, 1988
16. Wong SY, Path MRC, Carrol EDS et al.: Detection of estrogen receptor proteins in breast tumors using an improved APAAP immunohistochemical technique. Cancer 62: 2171- 2175, 1988
17. Wedad H, Mobbs BG: Comparative evaluation of ER-IHC and enzyme immunoassay for the quantitation of estrogen receptors in breast cancer. Am J Clin Pathol 91: 182-186, 1989
18. Patterson DA, Reid CP, Anderson TJ et al.: Assessment of oestrogen receptor content of breast carcinoma by immunohistochemical techniques on fixed and frozen tissue and by biochemical ligand binding assay. J Clin Pathol 43: 46-51, 1990
19. Sondergaard G, Pedersen KO, Paulsen SM: Estrogen receptor analyses in breast cancer: comparison of monoclonal immunohistochemical and biochemical methods. Eur J Cancer Clin Oncol 25: 1425-1429, 1989
20. Molino A, Bonetti F, Bonetti A et al.: Prognostic significance of estrogen receptors, determined by two different methods in breast cancer. Ann Oncol 1. (abstr 8.16), 1990
21. Pertschuk LP, Kim DS, Nayer K et al.: Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies. Cancer 66: 1663-1670, 1990
22. Katz RL, Patel S, Sneige N et al.: Comparison of immunocytochemical and biochemical assays for estrogen receptor in fine needle aspirates and histologic sections from breast carcinomas. Breast Cancer Res and Treat 15: 191-203, 1990
23. Allred DC, Bustamante MA, Daniel CO et al.: Immunocytochemical analysis of estrogen receptors in human breast carcinomas. Arch Surg 125: 107-113, 1990
24. Cudahy TJ, Boeryd BR, Franlund BK et al.: A comparison of three different methods for the determination of estrogen receptors in human breast cancer. Am J Clin Pathol 90: 583- 590, 1988
25. Molino A, Micciolo R, Turazza M et al.: Estrogen receptors in 699 primary breast cancers: a comparison of immunohistochemical and biochemical methods. Breast Cancer Res and Treat 34: 221-228, 1995
26. U.I.C.C. International Union Against Cancer: TNM Atlas. Illustrated guide to the TNM/pTNM classification of malignant tumours. Springer Verlag, Berlin, Heidelberg, 1992
27. EORTC Breast Cancer Co-operative Group. Revision of standards for the assessment of hormone receptors in human breast cancer: report of the second EORTC workshop, held on March 16-17, 1979, in the Netherlands Cancer Institute. Eur J Cancer 16: 1513-1515, 1980
28. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958
29. Cox DR: Regression models and life tables (with discussion). J Roy Stat Soc (B) 34: 187-220, 1972
30. Breslow N: Covariance analysis of censored survival data. Biometrics 30: 89-99, 1974
31. Dixon WJ: BMDP statistical software. University of California press, Berkeley, 1988
32. Thorpe SM, Rose C, Rasmussen BB et al.: Steroid hormone receptors as prognostic indicators in primary breast cancer. Breast Cancer Res Treat 7 (suppl) 91-98, 1974
33. DeSombre ER, Thorpe SM, Rose C et al.: Prognostic usefulness of estrogen receptor immunocytochemical assays for human breast cancer. Cancer Res 40(suppl): 4226s-4264s, 1986
34. Andersen J, Thorpe SM, King WJ et al.: The prognostic value of immunohistochemical estrogen receptor analysis in paraffin-embedded and frozen sections versus that of steroid-binding assays. Eur J Cancer 26(4): 442-449, 1990
35. Kinsel LB, Szabo E, Greene GL et al.: Immunocytochemical analysis of estrogen receptors as a predictor of prognosis in breast cancer patients: comparison with quantitative biochemical methods. Cancer Res 49: 1052-1056, 1989
36. Robertson JFR, Bates K, Pearson D et al.: Comparison of two oestrogen receptor assays in the prediction of the clinical course of patients with advanced breast cancer. Br J Cancer 65: 727-730, 1992
37. Querzoli P, Ferretti S, Marzola A et al.: Clinical usefulness of estrogen receptor immunocytochemistry in human breast cancer. Tumori 78(5): 287-290, 1992
38. Reiner A, Neumeister B, Spona J et al.: Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer. Cancer Res 50: 7057-7061, 1990
39. Beck T, Weikel W, Brumm C et al.: Immunohistochemical detection of hormone receptors in breast carcinomas (ERIHC, PgR-IHC): prognostic usefulness and comparison with the biochemical radioactive-ligand-binding assay (DCC). Gynecol Oncol 53: 220-227, 1994
40. Alexieva-Figusch I, Van Putten WLJ, Blankestein MA et al.: The prognostic value and relationships of patient characteristics, estrogen and progestin receptors, and site of relapse in primary breast cancer. Cancer 61: 758-768, 1988
41. Clark GM, Wenger CR, Beardsley S et al.: How to integrate steroid hormone receptor, flow cytometric, and other prognostic information in regard to primary breast cancer. Cancer 71: 2157-2162, 1993